ROYCE & ASSOCIATES LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$797,142
-30.8%
50,548
-14.6%
0.01%
-27.3%
Q2 2023$1,151,120
-14.8%
59,214
+24.3%
0.01%
-21.4%
Q1 2023$1,351,320
+31.4%
47,632
+35.3%
0.01%
+27.3%
Q4 2022$1,028,750
+63.0%
35,195
+47.4%
0.01%
+57.1%
Q3 2022$631,000
-53.3%
23,875
-21.5%
0.01%
-50.0%
Q2 2022$1,352,000
-25.4%
30,425
-16.9%
0.01%
-6.7%
Q1 2022$1,812,000
+90.9%
36,622
+96.4%
0.02%
+114.3%
Q4 2021$949,000
+2.0%
18,644
+11.8%
0.01%0.0%
Q3 2021$930,000
+37.6%
16,680
+5.6%
0.01%
+40.0%
Q2 2021$676,000
+7.6%
15,798
+4.9%
0.01%
+25.0%
Q1 2021$628,000
+6.6%
15,056
+19.0%
0.00%
-20.0%
Q4 2020$589,000
+9.1%
12,654
-0.5%
0.01%
-16.7%
Q3 2020$540,000
-70.2%
12,719
-66.3%
0.01%
-70.0%
Q2 2020$1,812,000
-23.7%
37,765
-26.9%
0.02%
-37.5%
Q1 2020$2,376,000
-20.9%
51,647
+3.3%
0.03%
+18.5%
Q4 2019$3,003,000
-9.7%
49,986
-14.9%
0.03%
-12.9%
Q3 2019$3,324,000
-11.7%
58,767
-13.1%
0.03%
-8.8%
Q2 2019$3,766,000
+15.7%
67,633
+4.9%
0.03%
+21.4%
Q1 2019$3,256,000
+117.6%
64,483
+73.6%
0.03%
+115.4%
Q4 2018$1,496,000
-47.4%
37,139
-9.5%
0.01%
-35.0%
Q3 2018$2,845,000
-6.6%
41,033
+1.9%
0.02%
-4.8%
Q2 2018$3,047,000
-17.4%
40,275
-42.5%
0.02%
-19.2%
Q1 2018$3,691,000
-24.3%
70,043
-23.3%
0.03%
-18.8%
Q4 2017$4,879,000
+20.4%
91,334
+34.5%
0.03%
+18.5%
Q3 2017$4,051,00067,9160.03%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders